XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America

Carlos Arturo Areán Martínez; Fernando Lanas; Ghazi Radaideh; Suleiman M. Kharabsheh; Marc Lambelet; Marco Antonio Lavagnino Viaud; Naser Samih Ziadeh; Alexander G.G. Turpie

doi:10.1016/j.ehj.2018.09.002

Q2 2018

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America

Carlos Arturo Areán Martínez · Fernando Lanas · Ghazi Radaideh · Suleiman M. Kharabsheh · Marc Lambelet · Marco Antonio Lavagnino Viaud · Naser Samih Ziadeh · Alexander G.G. Turpie

10.1016/j.ehj.2018.09.002 392 Views 23 Citations

Citations

392

Views

Abstract not available for this publication.

Cite this Article (APA)

Carlos, A. A. M., Fernando, L., Ghazi, R., Suleiman, M. K., Marc, L., Marco, A. L. V., Naser, S. Z., Alexander, G. T. (2018). XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America. Egyptian Heart Journal. https://doi.org/10.1016/j.ehj.2018.09.002